Basilea Pharmaceutica 2024 Investor Presentation Anti-Infectives

Basilea Pharmaceutica is a Swiss biopharmaceutical company focused on identifying and developing treatments for severe bacterial and fungal diseases with unmet medical needs. The company leverages two revenue-generating hospital anti-infective brands, Cresemba® and Zevtera®, addressing infections including Candida, Aspergillus, Fusarium, and antibiotic-resistant bacteria.